1-7 of 7
her2 positive
Close
Sort by
Journal Articles

Exceptionally Potent Cytotherapy Using T Cells Armed with Novel Tetravalent Recombinant Bispecific Antibodies Specific for GD2 and HER2

Jeong A Park, MD PhD, Hong Xu, PhD, Brian Santich, PhD, Nai-Kong V. Cheung, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4536.
https://doi.org/10.1182/blood-2018-99-120210
Published: 2018
Journal Articles

Copper-64-Labeled Daratumumab As a PET Imaging Tracer for Multiple Myeloma: Potential Use for Minimal Residual Disease Detection

Enrico Caserta, PhD, Junie Chea, Megan Minnix, Domenico Viola, BS, Steven Vonderfecht, Jonathan J Keats, PhD, James F Sanchez, David Colcher, John E. Shively, Amrita Krishnan, MD, Flavia Pichiorri, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3083.
https://doi.org/10.1182/blood.V130.Suppl_1.3083.3083
Published: 2017
Journal Articles

In Vitro Comparison of ADCC and CAR Sensitivity of Adult HER-2+ B-ALL Using the NK-92 Human Cell Line Transduced with a Human CD16 (ADCC) or an Anti-HER2 Chimeric Antigen Receptor (CAR)

Beatrice Clemenceau, PhD, Thierry Guillaume, MD PhD, Nelly Robillard, PhD, Regine Vivien, Pierre Peterlin, MD, Alice Garnier, MD, Marie-Christine Bene, Henri Vié, PhD, Patrice Chevallier, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5193.
https://doi.org/10.1182/blood.V128.22.5193.5193
Published: 2016
Journal Articles

Therapy-Related Myeloid Neoplasms in Breast Cancer Patients: A Single-Institution Report of 150 Cases

Katarina Sevcikova, MD, Zuo Zhuang, MD PhD, Guillermo Garcia-Manero, MD, Ricardo Alvarez, MD, Hagop M. Kantarjian, MD, Mego Michal, MD, Constance Albarracin, MD PhD, Guilin Tang, MD, Sara S. Strom, PhD, James M. Reuben, PhD, Joseph D Khoury, MD
Journal: Blood
Blood (2014) 124 (21): 962.
https://doi.org/10.1182/blood.V124.21.962.962
Published: 2014
Journal Articles

Synergistic Antitumor Effects of Chimeric Antigen Receptor-Modified T Cells and Oncolytic Virotherapy

Xingbing Wang, PhD MD, Stephen Gottschalk, MD, Xiao-Tong Song, PhD
Journal: Blood
Blood (2014) 124 (21): 5808.
https://doi.org/10.1182/blood.V124.21.5808.5808
Published: 2014
Journal Articles

Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL study

Brief Report
Patrice Chevallier, Nelly Robillard, Aude Charbonnier, Emmanuel Raffoux, Sebastien Maury, Sylvain Carras, Cecile Chabrot, Cecile Fohrer, Marc Bernard, Jean-Sebastien Blade, Anne Etienne, Pascaline Talmant, Jacques Delaunay, Thierry Guillaume, Mohamad Mohty, Marie-Christine Bene, Norbert Ifrah, Herve Dombret
Journal: Blood
Blood (2012) 119 (11): 2474–2477.
https://doi.org/10.1182/blood-2011-11-390781
Published: 2012
Journal Articles

Trastuzumab (Herceptin®) for Treatment of Refractory/Relapsed HER2 Positive Adult B-ALL: Results of a Phase II GRAALL Study

Patrice Chevallier, MD, Nelly Robillard, Aude Charbonnier, Emmanuel Raffoux, MD, PhD, Sébastien Maury, Sylvain Carras, Cecile Chabrot, Cecile Fohrer, Marc Bernard, Jean-Sebastien Blade, Anne Etienne, MD, Pascaline Talmant, Jacques Delaunay, Thierry Guillaume, Mohamad Mohty, Norbert Ifrah, Herve Dombret
Journal: Blood
Blood (2011) 118 (21): 1525.
https://doi.org/10.1182/blood.V118.21.1525.1525
Published: 2011